Tomooka, F.; Kaji, K.; Nishimura, N.; Kubo, T.; Iwai, S.; Shibamoto, A.; Suzuki, J.; Kitagawa, K.; Namisaki, T.; Akahane, T.;
et al. Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity. Cells 2023, 12, 687.
https://doi.org/10.3390/cells12050687
AMA Style
Tomooka F, Kaji K, Nishimura N, Kubo T, Iwai S, Shibamoto A, Suzuki J, Kitagawa K, Namisaki T, Akahane T,
et al. Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity. Cells. 2023; 12(5):687.
https://doi.org/10.3390/cells12050687
Chicago/Turabian Style
Tomooka, Fumimasa, Kosuke Kaji, Norihisa Nishimura, Takahiro Kubo, Satoshi Iwai, Akihiko Shibamoto, Junya Suzuki, Koh Kitagawa, Tadashi Namisaki, Takemi Akahane,
and et al. 2023. "Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity" Cells 12, no. 5: 687.
https://doi.org/10.3390/cells12050687
APA Style
Tomooka, F., Kaji, K., Nishimura, N., Kubo, T., Iwai, S., Shibamoto, A., Suzuki, J., Kitagawa, K., Namisaki, T., Akahane, T., Mitoro, A., & Yoshiji, H.
(2023). Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity. Cells, 12(5), 687.
https://doi.org/10.3390/cells12050687
